Hisashi Wada

12PUBLICATIONS
36CO-AUTHORS
Tumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 08, 2026
PD-1 antibody-bound progenitor-exhausted CD8+ T cells in lymph nodes boost PD-1-blockade anti-tumor immunity in gastrointestinal cancer.

Yohei Nose, Yoshiaki Yasumizu, Takuro Saito

|Feb 07, 2024
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.

Takuro Saito, Yukinori Kurokawa, Kazumasa Fujitani

|Sep 20, 2023
Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors.

Kaoru Fujikawa, Takuro Saito, Koji Kurose

|Jul 07, 2023
S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells.

Yoji Nagira, Morio Nagira, Ryohei Nagai

|Jun 23, 2023
Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile.

Azumi Ueyama, Wataru Nogami, Kunitaka Nashiki

|Apr 04, 2023
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.

Yoshinori Hayashi, Tomoki Makino, Eiichi Sato

Pageof 2

Frequent Collaborators

3 joint publications

Takuro Saito

3 joint publications

Tsuyoshi Takahashi

2 joint publications

Kazuhiro Kakimi

2 joint publications

Yukinori Kurokawa